The COVID-19 Effect:
How Pharma Can Adapt to the Evolving Patient Experience
How Pharma Can Adapt to the Evolving Patient Experience
By listening to the people who are navigating this new landscape everyday.
Integrating personal experiences and patient-reported data, Health Union recently hosted a one-day virtual event featuring real-time conversations between people living with chronic conditions and industry experts.
Below, access all of the session recordings based on your interests and hear from patient advocates living with migraine, MS, psoriasis, and lung cancer; plus a telehealth-focused roundtable featuring advocates living with Parkinson’s disease and IBD.
MS & Social Distancing: Devin’s Resilience
Integrating Devin’s personal MS experience with Health Union’s patient-reported data, this interview focuses on what’s changed or stayed the same throughout the pandemic, thoughts on telehealth, and the ups and downs of Devin’s 20-year journey with MS.
Psoriasis Used to Isolate Reena, Now It Connects Her
Accompanied by Health Union’s patient-reported data, this session dives into Reena’s unique experience living with psoriasis, focusing on her relationship with HCPs, the positive impact of online connections and advice for pharma.
Healthcare + Self-Care: Kerrie’s Migraine Journey
Coupled with Health Union’s patient-reported data, Kerrie shares what she wishes she knew at the start of her migraine journey, details her shift to self-care and experiences with telehealth, and offers food for thought for pharma.
Listen & Learn From People With Lung Cancer, Like Lisa
Lisa will discuss her personal experience living with late stage lung cancer, alongside Health Union’s patient-reported data, focusing on changing treatment during the pandemic, how she copes with isolation and tips for pharma.
Telehealth Perspectives: The Good, The Bad & The Ugly
Through the personal experiences of Health Union patient advocates living with Parkinson’s disease and IBD, this telehealth roundtable focuses on challenges, opportunities and impact on the HCP-patient relationship.